Current Health News: Major Updates and Developments
The latest health news includes Calley Means leaving the White House, Cipla CEO Umang Vohra stepping down, U.S. FDA's fluoride warnings, Mayne Pharma's bid block, ACL injury risks in girls, bacteriophage potential, Novo Nordisk job cuts, Hungary's bird flu outbreak, Pfizer's acquisition clearance, and Eli Lilly's weight-loss pill.
In significant updates from the health sector, Calley Means, health adviser to U.S. Health Secretary Robert F. Kennedy Jr., has departed the White House. The New York Times reported that Means, previously part of the Trump administration, played a key role in the "Make America Healthy Again" initiative.
Amidst executive changes, Cipla's CEO Umang Vohra will step down in March, with COO Achin Gupta set to succeed him in 2026. Meanwhile, the U.S. FDA has issued warnings against four companies selling unapproved fluoride drugs for children.
Additional highlights include Australia's Mayne Pharma facing a blocked buyout bid, a study linking childhood movement to ACL injuries, potential of bacteriophage in treating bacterial infections, Novo Nordisk's job cuts, an avian flu outbreak in Hungary, Pfizer's antitrust clearance for a significant acquisition, and Eli Lilly's promising weight-loss medication.
Google News